IDH1 for Ivosidenib (Tibsovo)

Alphabetical Test listing

IDH1 for Ivosidenib (Tibsovo)-994

November 30, 2021

Due to reagent procurement issues and/or staffing shortages at Versiti, the turn-around-time for this assay may be extended.

  
IDH1 for Ivosidenib (Tibsovo)
  
994
  
LAB994
  
MSO
  
IDH Isocitrate dehydrogenase 1
  

An aid in identifying acute myeloid leukemia (AML) patients with an isocitrate dehydrogenase-1 (IDH1) mutation for treatment with TIBOSVO® (ivosidenib).

  
EDTA whole blood
  
  
5.0 mL
  
1.0 mL
  

Do not spin; submit entire specimen

  

Lavender (EDTA), 4mL

  
EDTA bone marrow
  

Lavender (EDTA), 4mL

  
  • Indicate on specimen tube and requisition whether sample is from whole blood or bone marrow.
  • Versiti requisition form
  • Molecular Medicare billing request
    • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
    • All information requested is required in order for your request to be completed
  

Refrigerated

  
Versiti Blood Center of WI (7647): R-NX
  
5 - 7 days
  

Abbott Realtime IDH1

  
This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.
  
81120
  
Yes
  
  
06/10/2019
  
11/15/2019